Vascular injury biomarkers and stroke risk

Objective Because little is known about associations between biomarkers of vascular injury and stroke risk, we evaluated associations between plasma concentrations of 6 novel biomarkers of vascular injury and stroke risk in a population-based study. Methods A case–cohort subset of EPIC-Heidelberg (European Prospective Investigation for Cancer and Nutrition–Heidelberg) including incident stroke cases (n = 335) and a random subcohort (n = 2,418) was selected. Concentrations of intercellular adhesion molecule 3 (ICAM3), soluble E-selectin and P-selectin, soluble thrombomodulin (sTM), thrombopoietin, and glycoprotein IIb/IIIa were measured in baseline plasma samples. Weighted Cox regression analyses were used to assess associations between biomarker levels and stroke risk. Results Median follow-up in the subcohort and among cases was 9.8 (range, 0.1–12.5) years and 6.2 (range, 0.01–12.1) years, respectively. ICAM3 levels were associated with increased risk of incident stroke after multivariable adjustment (hazard ratio, highest vs lowest quartile: 1.64 [95% confidence interval, 1.15–2.32]; plinear trend < 0.001). This association was more apparent for ischemic (1.65 [1.12–2.45]; plinear trend < 0.01) than for hemorrhagic stroke (1.29 [0.60–2.78]; plinear trend = 0.3). We further observed a borderline significant trend for a positive association between sTM and overall stroke risk (1.47 [0.99–2.19]; plinear trend = 0.05). Conclusions In this population-based study, circulating levels of ICAM3, an adhesion molecule shed by leukocytes, were associated with increased risk of incident stroke. Further mechanistic studies are needed to elucidate the pathophysiology underlying this association. Classification of evidence This study provides Class II evidence that plasma levels of ICAM3 are associated with increased stroke risk.

[1]  M. Kloss,et al.  Biomarkers of vascular injury in relation to myocardial infarction risk: A population-based study , 2019, Scientific Reports.

[2]  M. Hoffmeister,et al.  Pre‐diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP‐selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study , 2018, International journal of cancer.

[3]  L. Goldstein,et al.  Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial , 2017, Stroke.

[4]  M. Hoffmeister,et al.  Biological reproducibility of circulating P-Selectin, Thrombopoietin, GPIIb/IIIa and Thrombomodulin over one year. , 2017, Clinical biochemistry.

[5]  H. Parving,et al.  Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria. , 2016, Journal of diabetes and its complications.

[6]  G. Deuschl,et al.  Determinants of Platelet-Leukocyte Aggregation and Platelet Activation in Stroke , 2015, Cerebrovascular Diseases.

[7]  K. Kaushansky,et al.  Thrombopoietin from beginning to end , 2014, British journal of haematology.

[8]  E. Grove,et al.  Platelet Turnover in Stable Coronary Artery Disease – Influence of Thrombopoietin and Low-Grade Inflammation , 2014, PloS one.

[9]  Kathleen F. Kerr,et al.  Testing for improvement in prediction model performance , 2013, Statistics in medicine.

[10]  G. Jickling,et al.  Ischemic stroke biomarkers in blood. , 2013, Biomarkers in medicine.

[11]  E. Ingelsson,et al.  Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. , 2012, American journal of epidemiology.

[12]  H. Griffiths,et al.  Apoptotic cell-derived ICAM-3 promotes both macrophage chemoattraction to and tethering of apoptotic cells , 2011, Cell Death and Differentiation.

[13]  S. Jackson.  Arterial thrombosis—insidious, unpredictable and deadly , 2011, Nature Medicine.

[14]  F. Sharp,et al.  Blood Biomarkers of Ischemic Stroke , 2011, Neurotherapeutics.

[15]  C. Meisinger,et al.  Soluble thrombomodulin in coronary heart disease: lack of an association in the MONICA/KORA case–cohort study , 2011, Journal of thrombosis and haemostasis : JTH.

[16]  M. Elkind.  Inflammatory mechanisms of stroke. , 2010, Stroke.

[17]  E. Boerwinkle,et al.  Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. , 2007, Atherosclerosis.

[18]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[19]  C. Meisinger,et al.  Soluble thrombomodulin as a predictor of type 2 diabetes: results from the MONICA/KORA Augsburg case–cohort study, 1984–1998 , 2007, Diabetologia.

[20]  J. Trowsdale,et al.  Human atherosclerotic plaques express DC‐SIGN, a novel protein found on dendritic cells and macrophages , 2002, The Journal of pathology.

[21]  R. McEver.  Selectins: lectins that initiate cell adhesion under flow. , 2002, Current opinion in cell biology.

[22]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[23]  N. Day,et al.  Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. , 2002, International journal of epidemiology.

[24]  E. Boerwinkle,et al.  Thrombomodulin Ala455Val Polymorphism and Risk of Coronary Heart Disease , 2001, Circulation.

[25]  V. Salomaa,et al.  Soluble thrombomodulin as predictor of incident coronary heart disease , 1999, The Lancet.

[26]  H. Boeing,et al.  Follow-Up Procedures in EPIC-Germany – Data Quality Aspects , 1999, Annals of Nutrition and Metabolism.

[27]  H. Boeing,et al.  EPIC-Germany – A Source for Studies into Diet and Risk of Chronic Diseases , 1999, Annals of Nutrition and Metabolism.

[28]  H. Boeing,et al.  Recruitment Procedures of EPIC-Germany , 1999, Annals of Nutrition and Metabolism.

[29]  F. Sánchez‐Madrid,et al.  ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands , 1994, The Journal of cell biology.

[30]  L. McIntire,et al.  P-selectin mediates neutrophil rolling on histamine-stimulated endothelial cells. , 1993, Biophysical journal.

[31]  S. Greenland,et al.  Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. , 1992, American journal of epidemiology.

[32]  T. Springer,et al.  Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes , 1992, The Journal of experimental medicine.

[33]  A. Schienkiewitz,et al.  Prevalence of stroke in adults aged 40–79 years in Germany , 2013 .

[34]  L. Fuentes,et al.  Secreted phospholipase A2 type IIA as a mediator connecting innate and adaptive immunity: new role in atherosclerosis. , 2009, Cardiovascular research.

[35]  J. Karvanen,et al.  Epidemiologic Perspectives & Innovations Open Access Case-cohort Design in Practice – Experiences from the Morgam Project , 2007 .

[36]  H. Boeing,et al.  Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. , 1999, Annals of nutrition & metabolism.

[37]  T. Lamparelli,et al.  Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse. , 1998, Haematologica.

[38]  R. Prentice,et al.  Aspects of the use of relative risk models in the design and analysis of cohort studies and prevention trials. , 1988, Statistics in medicine.